In May of 2020, the Centers for Medicare and Medicaid Services (CMS) published the annual Notice of Benefit and Payment Parameters rule, outlining the framework within which plans can operate these tactics in the coming year. Specific provisions regarding state laws, generic availability, and other factors create a complex dynamic that is critical for pharmaceutical industry leaders overseeing co-pay programs to fully understand in order to assess their program’s risk, monitor impact, and implement an effective mitigation strategy.
In this webinar, discover:
- How the 2021 Notice of Benefit and Payment Parameters will impact co-pay programs in 2021
- Emerging trends and market developments influencing how accumulators and maximizers are utilized
- Key resources for building an effective mitigation strategy